TY - JOUR
T1 - SATB1 is a targetable modulator of JAK-STAT signaling and cytokines in human Treg and Tconv cells
AU - Kolb, Saskia
AU - Diekmann, Leonie
AU - Lochert, Elizabeth E.
AU - Warmuth, Linda
AU - Ritter, Julia
AU - Schmidtke, Gunter
AU - Weber, Michael
AU - Hoffmann, Markus
AU - List, Markus
AU - Kotlarz, Daniel
AU - Serr, Isabelle
AU - Daniel, Carolin
AU - Busch, Dirk H.
AU - Schmidl, Christian
AU - Schumann, Kathrin
N1 - Publisher Copyright:
© The Author(s) 2026.
PY - 2026
Y1 - 2026
N2 - The chromatin organizer SATB1 is indispensable for thymic regulatory T cell (Treg cell) development and T helper cell induction. Several gene loci have been described to be SATB1-controlled, including the transcription factor GATA3 and the cytokine loci IL-4 and IL-17. However, the global effects of SATB1 on fully differentiated human CD4 conventional T cells (Tconv cells) and Treg cells, and thus the potential of SATB1 as a target for T-cell engineering, are poorly understood. Here, we describe SATB1-regulated gene signatures as largely subset-specific, with broader effects on Treg cells. Despite distinct gene-regulatory patterns, we observe overarching dysregulated cytokine and JAK-STAT signaling after SATB1 ablation. Functionally, SATB1 KO reduces suppressive capacities of human Treg cells but boosts tumor clearance via CD4 CAR T cells in a preclinical, humanized mouse model. Taken together, Treg destabilization and simultaneous increased activation of CD4 CAR T cells by SATB1 modulation may be a strategy to boost the efficiency of CAR T cell therapies.
AB - The chromatin organizer SATB1 is indispensable for thymic regulatory T cell (Treg cell) development and T helper cell induction. Several gene loci have been described to be SATB1-controlled, including the transcription factor GATA3 and the cytokine loci IL-4 and IL-17. However, the global effects of SATB1 on fully differentiated human CD4 conventional T cells (Tconv cells) and Treg cells, and thus the potential of SATB1 as a target for T-cell engineering, are poorly understood. Here, we describe SATB1-regulated gene signatures as largely subset-specific, with broader effects on Treg cells. Despite distinct gene-regulatory patterns, we observe overarching dysregulated cytokine and JAK-STAT signaling after SATB1 ablation. Functionally, SATB1 KO reduces suppressive capacities of human Treg cells but boosts tumor clearance via CD4 CAR T cells in a preclinical, humanized mouse model. Taken together, Treg destabilization and simultaneous increased activation of CD4 CAR T cells by SATB1 modulation may be a strategy to boost the efficiency of CAR T cell therapies.
UR - https://www.scopus.com/pages/publications/105041862006
U2 - 10.1038/s44319-026-00812-6
DO - 10.1038/s44319-026-00812-6
M3 - Article
AN - SCOPUS:105041862006
SN - 1469-221X
JO - EMBO Reports
JF - EMBO Reports
ER -